|
Elisigen
has appointed Dr. Jinkuk Choi as Chief Strategy Officer and established a new
Strategy Office to strengthen its global growth, business development, and
licensing-out capabilities alongside advancing its AAV gene therapy pipeline.
|
Read Original Article (Korean)
*Note: This link will redirect you to the original source in Korean.